DAY 1: ACADEMIC DRUG DISCOVERY
25 FEB 2020
07:30 – 08:30
Registration
Opening Ceremony & Lectures
08:25 – 08:30
Recitation from Holy Quran
Reciter
8:45 – 8:55
Welcome Address
09:00 – 09:20
Open for Collaboration – An Academic Platform for Drug Discovery & Development at SciLifeLab
09:20 – 09:40
Overview Of Industrial Sector In Light Of Vision 2030
09:40 – 10:10
Drug Discovery in Academia: View from Venture Capital.
10:10 – 10:30
Coffee Break
10:30 – 10:50
Inborn Errors of Metabolism Drug Discovery: an update
10:50 – 11:10
Structure-guided drug discovery for rare metabolic disorders’
11:10 – 11:30
The Druggable Genome: Opportunities for Saudi Arabia
11:30 – 11:40
Nutritional considerations for integrative health care in children with sickle cell disease with specific reference to omega-3 fatty acids, Dr. Shahida Aziz Khan, King Fahd Medical Research Center, Jeddah, Kingdom of Saudi Arabia
11:40 – 11:50
A novel investigational oral therapy for SGCE myoclonus-dystonia syndrome: the outcome of 6 months trial.
11:50 – 12:00
Development and validation of LC-MS/MS method for quantitation of N-acetylated amino acids in aminoacylase I deficiency patients
12:00 – 1:00
Prayer & Lunch Break
01:00 – 10:20
Computational strategies to design first-in-class DNA methyl transferase inhibitors: activation of antitumor immune response
01:20 – 01:40
Wiskott-Aldrich Syndrome Protein Regulates Nuclear Organization, Alternative Splicing and Cell Proliferation
01:40 – 02:00
Approval lifecycle for therapeutics antibodies in Saudi FDA
02:00 – 02:20
A drug repositioning approach identifies a combination of compounds as a potential regimen for Chronic Lymphocytic Leukemia treatment
02:20 – 02:40
Mass Spectrometry Imaging method and its’ application in drug research and development
02:40 – 03:00
The Saudi MD Clinical Trial infrastructure
03:00 – 03:30
Break and Exhibition Tour
DAY 2:
08:00 – 08:30
Welcome and Coffee
08:30 – 08:50
Predicting Drug Resistance by Applying Machine Learning to Molecular Simulation
08:50 – 09:10
Fragment Based Approaches as a Computational Chemistry tool in the Design of Novel Molecules in Drug Discovery
09:10 – 09:25
Molecular Dynamic Simulation for early target identification for the treatment of Dengue Fever
09:25 – 09:40
The role of Microbiome bioinformatics analysis in drug discovery towards discovering treatment for bacterial vaginosis.
09:40 –09:55
Bioinformatics method for identification of somatic mutations in cancer and their functional relevance
09:55 – 10:10
Insilico screening pipeline for the identification of peptide as the basis for treatment for MERS-CoV
10:10—10:30
Short Coffee Break
10:30 – 11:00
Importance of antibiotic surveillance studies and Survey of Antibiotic Resistance (SOAR): Their contribution to new drug discovery.
11:15 – 11:35
The Challenges and Opportunities of Novel Anti-DR TB Drugs R&D in China
11:35 – 11:50
Bioactive Constituents from Extremophilic Fungi-New Leads to Battle Multi-resistant Microbes and Cancer Cells
11:50 – 12:10
Antibody Phage Display for Infectious Diseases, Prof. Lim Theam Soon, Dr. rer. Nat, Institute for Research in Molecular Medicine Universiti Sains Malaysia
12:10 – 01:00
Prayer and Lunch Break
01:00 – 01:20
Watch your step, there is new chemistry everywhere.
01:20 – 01:40
Protein target profiling of bioactive natural products
01:40 – 02:00
Combinatorial Chemistry and Drug Discovery
02:00 – 02:20
NATURAL PRODUCTS AS ANTI-GLYCATION AGENTS: POSSIBLE THERAPY FOR DIABETIC COMPLICATIONS?
02:20 – 02:40
Under Review
02:40 – 03:00
Panel Discussion: Q & A to the speakers
03:00 – 03:30
Break and Exhibition Tour
03:30 – 03:45
The achievements of academic drug discovery
03:45 – 04:00
Pharma Cluster Introduction in KSA, Landscape & Opportunities
04:00 – 04:15
Physical PEGylation Enhances the Cytotoxicity of 5-Flurouracil Loaded PLGA and PCL Nanoparticles
04:15 – 04:30
New mechanistic insights into a potential allergic response of silver nanomaterials
04:30 – 05:00
Panel Discussion: Q & A to the speakers